Tolerance Induction Using Autologous Regulatory T Cell Infusion and Zortress (Everolimus) in Renal Transplant Recipients: a pilot study

Grants and Contracts Details

StatusFinished
Effective start/end date2/28/177/31/23

Funding

  • Novartis (domestic): $114,863.00